Dalmane and Breastfeeding

In studies on Dalmane and breastfeeding, the medication was shown to pass through breast milk. Due to the potentially serious side effects that can occur, women are usually advised to stop breastfeeding during treatment. If your healthcare provider does recommend taking Dalmane while breastfeeding, watch for certain side effects in your infant, such as decreased feeding or slow development.

Dalmane and Breastfeeding: An Overview

Dalmane® (flurazepam) passes through breast milk. Therefore, if you are breastfeeding or are thinking of breastfeeding, it is important to talk with your healthcare provider about taking Dalmane during this time.
 

Dalmane and Breastfeeding: What Does the Research Say?

Studies have shown that Dalmane passes through breast milk in women. Because the drug can cause serious side effects, it is usually recommended that women stop breastfeeding while taking it. If your healthcare provider recommends taking Dalmane while breastfeeding, be sure to watch for any side effects in your child. In particular, be sure to watch for:
 
  • Drowsiness
  • Decreased feeding
  • Slow weight gain
  • Slow development.
 

Talking With Your Healthcare Provider About Dalmane and Breastfeeding

You should talk with your healthcare provider about Dalmane and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Dalmane and breastfeeding that is right for you.
Baby Milestones You've Never Heard Of

Dalmane Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.